The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production
Open accessAbstract
A critical step in preserving protein homeostasis is the recognition, binding, unfolding, and translocation of protein substrates by six AAA-ATPase proteasome subunits (ATPase-associated with various cellular activities) termed PSMC1-6, which are required for degradation of proteins by 26 S proteasomes. Here, we identified 15 de novo missense variants in the PSMC3 gene encoding the AAA-ATPase proteasome subunit PSMC3/Rpt5 in 23 unrelated heterozygous patients with an autosomal dominant form of neurodevelopmental delay and intellectual disability. Expression of PSMC3 variants in mouse neuronal cultures led to altered dendrite development, and deletion of the PSMC3 fly ortholog Rpt5 impaired reversal learning capabilities in fruit flies. Structural modeling as well as proteomic and transcriptomic analyses of T cells derived from patients with PSMC3 variants implicated the PSMC3 variants in proteasome dysfunction through disruption of substrate translocation, induction of proteotoxic stress, and alterations in proteins controlling developmental and innate immune programs. The proteostatic perturbations in T cells from patients with PSMC3 variants correlated with a dysregulation in type I interferon (IFN) signaling in these T cells, which could be blocked by inhibition of the intracellular stress sensor protein kinase R (PKR). These results suggest that proteotoxic stress activated PKR in patient-derived T cells, resulting in a type I IFN response. The potential relationship among proteosome dysfunction, type I IFN production, and neurodevelopment suggests new directions in our understanding of pathogenesis in some neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These variants affect the protein levels of proteasome subunits, or decreases their incorporation into 20S and 26S proteasome and also the assembly of 20S and 26S proteasome [18–20, 22, 23].”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The inheritance pattern for these disorders can either be dominant, for the majority of variants in PSMD12 [Stankiewicz-Isidor syndrome, MIM: 617516]9,10, PSMC311 and PSMD1112, or recessive, as observed in cases involving PSMB1 [MIM: 620038]13 and PSMC3 [MIM: 619354]14 variants (Supplementary Fig. 1).”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“However, Rpt6 KD caused significant defect in the ability to acquire novel association after initial training—a different behavior paradigm known as reversal learning (Tukey, p < 0.0001; N = 4; Fig. 3b), which is similar to what we previously reported in proteasome subunit gene PSMC3 KD models11.”
From Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies (2025) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, mutations in genes encoding proteasome subunits result in neurodevelopmental disorders, as exemplified by variants of genes encoding the 20S CP subunit PSMB1 (β1) [18] and the 19S RP subunits PSMC3 [19, 20] and PSMD12 [21–23].”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Previous published work has shown that nonsense or missense variants of proteasome subunits PSMB1 [18], PSMC3 [19, 20], and PSMD12 [22, 23] are associated with neurodevelopmental disorders.”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
Perez-Riverol, Y., Bai, J., Bandla, C., García-Seisdedos, D., Hewapathirana, S., Kamatchinathan, S., Kundu, D. J., Prakash, A., Frericks-Zipper, A., Eisenacher, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1038 · Cited by 6,125
The neuropathological diagnosis of Alzheimer's disease
DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184 · cited 1×
“The proteasome is part of the ubiquitin-proteasome system (UPS), which counts numerous enzymes acting upstream of the proteasome (7, 8).”
BackgroundSequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Taliun, S. A. G., Corvelo, A., Gogarten, S. M., Kang, H. M., et al. (2021) · Nature · doi:10.1038/s41586-021-03205-y · Cited by 2,213
GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.
Sobreira, N., Schiettecatte, F., Valle, D., & Hamosh, A. (2015) · Human Mutation · doi:10.1002/humu.22844 · Cited by 1,529
Classical conditioning and retention in normal and mutantDrosophila melanogaster
Tully, T., & Quinn, W. G. (1985) · Journal of Comparative Physiology A · doi:10.1007/bf01350033 · Cited by 1,183
Polyubiquitin chains: polymeric protein signals
Pickart, C. M., & Fushman, D. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.09.009 · Cited by 1,049
Meurs, E., Chong, K., Galabru, J., Thomas, N. S. B., Kerr, I. M., Williams, B. R. G., & Hovanessian, A. G. (1990) · Cell · doi:10.1016/0092-8674(90)90374-n · Cited by 1,017
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 1,000
Cited by
GestaltMatcher facilitates rare disease matching using facial phenotype descriptors
Hsieh, T.-C., Bar-Haim, A., Moosa, S., Ehmke, N., Gripp, K. W., Pantel, J. T., Danyel, M., Mensah, M. A., Horn, D., Rosnev, S., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-01010-x · Cited by 233
Self-citationSchmidt, A., Danyel, M., Grundmann, K., Brunet, T., Klinkhammer, H., Hsieh, T., Engels, H., Peters, S., Knaus, A., Moosa, S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01836-1 · Cited by 79
“After the end of the study, two more candidate genes transitioned to the group of DGGs due to additional phenotypic, functional and statistical evidence became available 32,34 .”
Self-citationGoldbach‐Mansky, R. T., Alehashemi, S., & de Jesus, A. A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01184-8 · Cited by 54
“…found increased PKR phosphorylation, an increase in an interferon response genes signature and compensatory upregulation of autophagy and mitophagy 196 ; however, a compartmentalized role of type I interferon in modifying clinical features of NDD and autism spectrum disorder in the CNS has not…”
Papendorf, J. J., Ebstein, F., Alehashemi, S., Piotto, D. G. P., Kozlova, A., Terreri, M. T., Shcherbina, A., Rastegar, A., Rodrigues, M., Pereira, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1190104 · Cited by 38
“These results indicate that, despite different organ manifestations, the molecular mechanisms driving the clinically different disease manifestations are similar but may act in a tissue specific manner (43).”
BackgroundSelf-citationLesmann, H., Hustinx, A., Moosa, S., Klinkhammer, H., Marchi, E. J., Caro, P., Abdelrazek, I. M., Pantel, J. T., ten Hagen, M., Thong, M., et al. (2023) · medRxiv · doi:10.1101/2023.06.06.23290887 · Cited by 39
“For example, Ebstein et al. showed that facial dysmorphism is more heterogeneous among their PSMC3 patient cohort, but more similarities were found in patients with identical variants 22 .”
Self-citation
Metadata
- Authors
- Ebstein, F., Küry, S., Most, V., Rosenfelt, C., Scott-Boyer, M.-P., van Woerden, G. M., Besnard, T., Papendorf, J. J., Studencka-Turski, M., Wang, T., Hsieh, T.-C., Golnik, R., Baldridge, D., Forster, C., de Konink, C., Teurlings, S. M. W., Vignard, V., van Jaarsveld, R. H., Ades, L., Cogné, B., Mignot, C., Deb, W., Jongmans, M. C. J., Cole, F. S., van den Boogaard, M.-J. H., Wambach, J. A., Wegner, D. J., Yang, S., Hannig, V., Brault, J. A., Zadeh, N., Bennetts, B., Keren, B., Gélineau, A.-C., Powis, Z., Towne, M., Bachman, K., Seeley, A., Beck, A. E., Morrison, J., Westman, R., Averill, K., Brunet, T., Haasters, J., Carter, M. T., Osmond, M., Wheeler, P. G., Forzano, F., Mohammed, S., Trakadis, Y., Accogli, A., Harrison, R., Guo, Y., Hakonarson, H., Rondeau, S., Baujat, G., Barcia, G., Feichtinger, R. G., Mayr, J. A., Preisel, M., Laumonnier, F., Kallinich, T., Knaus, A., Isidor, B., Krawitz, P., Völker, U., Hammer, E., Droit, A., Eichler, E. E., Elgersma, Y., Hildebrand, P. W., Bolduc, F., Krüger, E., & Bézieau, S.
- Affiliations
- Universitätsmedizin Greifswald (DE)
- Centre National de la Recherche Scientifique (FR)
- Leipzig University (DE)
- University of Alberta (CA)
- Research Center of Quebec CHU-Université Laval, Québec, QC PQ G1E6W2, Canada.
- Department of Neuroscience, Erasmus University Medical Center, 3015 CN, Rotterdam, Netherlands.
- Institut für Medizinische Biochemie und Molekularbiologie (IMBM), Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.
- University of Washington (US)
- University of Bonn (DE)
- University Hospital in Halle (DE)
- Washington University in St. Louis (US)
- GeneDx, 207 Perry Parkway, Gaithersburg, MD 20877, USA.
- Erasmus MC (NL)
- Department of Genetics, University Medical Center Utrecht, 3508 AB, Utrecht, Netherlands.
- Department of Clinical Genetics, Children’s Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.
- University Medical Center Utrecht (NL)
- Vanderbilt University Medical Center (US)
- Children's Hospital of Orange County (US)
- The University of Sydney (AU)
- Assistance Publique – Hôpitaux de Paris (FR)
- Ambry Genetics (United States) (US)
- Geisinger Health System (US)
- Seattle Children's Hospital (US)
- Orlando Health (US)
- St. Luke's Clinic (US)
- The University of Texas at San Antonio Health Science Center (US)
- Helmholtz Munich (DE)
- LMU Klinikum (DE)
- University of Ottawa (CA)
- Guy's Hospital (GB)
- McGill University Health Centre (CA)
- Nottingham University Hospitals NHS Trust (GB)
- Children's Hospital of Philadelphia (US)
- Hôpital Necker-Enfants Malades (FR)
- Paracelsus Medical University (AT)
- Université de Tours (FR)
- Leibniz Association (DE)
- Université Laval (CA)
- Howard Hughes Medical Institute (US)
- Humboldt-Universität zu Berlin (DE)
- Nantes Université, CHU Nantes, Service de Génétique Médicale, 44000 Nantes, France.
- Corresponding author
- Ebstein, Frédéric
- Küry, Sébastien
- Bolduc, François
- Krüger, Elke
- ORCID
- Ebstein, Frédéric
- Küry, Sébastien
- Most, Victoria
- Rosenfelt, Cory
- van Woerden, Geeske M.
- Besnard, Thomas
- Studencka-Turski, Maja
- Wang, Tianyun
- Hsieh, Tzung-Chien
- Golnik, Richard
- Baldridge, Dustin
- de Konink, Charlotte
- Teurlings, Selina M.W.
- Vignard, Virginie
- Cogné, Benjamin
- Mignot, Cyril
- Deb, Wallid
- Jongmans, Marjolijn C.J.
- Cole, F. Sessions
- van den Boogaard, Marie-José H.
- Wambach, Jennifer A.
- Wegner, Daniel J.
- Yang, Sandra
- Bennetts, Bruce
- Keren, Boris
- Powis, Zöe
- Towne, Meghan
- Bachman, Kristine
- Seeley, Andrea
- Beck, Anita E.
- Morrison, Jennifer
- Averill, Kelly
- Brunet, Theresa
- Haasters, Judith
- Carter, Melissa T.
- Osmond, Matthew
- Wheeler, Patricia G.
- Forzano, Francesca
- Mohammed, Shehla
- Trakadis, Yannis
- Accogli, Andrea
- Harrison, Rachel
- Guo, Yiran
- Hakonarson, Hakon
- Rondeau, Sophie
- Baujat, Geneviève
- Barcia, Giulia
- Feichtinger, René Günther
- Mayr, Johannes Adalbert
- Preisel, Martin
- Laumonnier, Frédéric
- Kallinich, Tilmann
- Knaus, Alexej
- Isidor, Bertrand
- Krawitz, Peter
- Völker, Uwe
- Hammer, Elke
- Droit, Arnaud
- Eichler, Evan E.
- Elgersma, Ype
- Hildebrand, Peter W.
- Bolduc, François
- Krüger, Elke
- Bézieau, Stéphane
- Venue
- Science Translational Medicine
- Published
- 2023-05-31
- Volume
- 15
- Issue
- 698
- Pages
- eabo3189-eabo3189
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC10506367
- OpenAlex
- W4378802689
- Cited by
- 36
- References
- 118
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 13 · 2023: 7
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- other-oa
- Locations
- Science Translational Medicine (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Genome Canada (OGI‐147)
- Wellcome Trust
- Ontario Genomics
- Simons Foundation Autism Research Initiative (608045)
- E-Rare
- Ontario Genomics Institute (OGI‐147)
- Genome British Columbia
- Deutsche Forschungsgemeinschaft (Project B4), SFBTR167)
- Agence Nationale de la Recherche (ANR-21-CE17-0005, ANR-22-RAR4-0001)
- Austrian Science Fund (I4695-B)
- Genome Alberta
- National Institutes of Health
- Canadian Institutes of Health Research
- Fundamental Research Funds for the Central Universities (BMU2022RCZX038)
- National Institute of Mental Health (R01MH101221)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- proteasome subunits, AAA+ ATPase, neurodevelopmental delay, intellectual disability, de novo missense variant, proteotoxic stress, proteostasis, dendrite formation, T cells, type I interferon signaling, PKR, innate immunity, proteasome dysfunction, reversal learning
- MeSH terms
- ATPases Associated with Diverse Cellular Activities, Adenosine Triphosphatases, Animals, Drosophila melanogaster, Humans, Interferon Type I, Endopeptidases, Gene Expression, Drosophila Proteins, Proteomics, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. https://app.cochat.ai/papers/10.1126/scitranslmed.abo3189
- The paper
- Ebstein, F., Küry, S., Most, V., Rosenfelt, C., Scott-Boyer, M.-P., van Woerden, G. M., Besnard, T., Papendorf, J. J., Studencka-Turski, M., Wang, T., Hsieh, T.-C., Golnik, R., Baldridge, D., Forster, C., de Konink, C., Teurlings, S. M. W., Vignard, V., van Jaarsveld, R. H., Ades, L., . . . Bézieau, S. (2023). PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abo3189
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.